Givaudan SA (GIVN) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Givaudan SA CHF 1,523, price CHF 3,406, upside -55.3%, quality 70 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Givaudan SA for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 25, 2026.
How to read this chart
60‑month range CHF 2,507 – CHF 4,463 · fair‑value band CHF 1,024 – CHF 2,619 · the CHF 3,406 price screens above the CHF 1,523 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 25, 2026.
Follow Givaudan in your weekly email
Every Wednesday you see whether Givaudan is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing.
Show more
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, and alcoholic drinks; dairy and cheese products, including dairy drinks, yoghurt, ice cream, chilled desserts, cream cheese, and spreads; snacks; givaudan flavour ingredients; savory, and supplements and nutraceutical products; and biscuits, crackers, and cereals, as well as confectionery products, such as chewing gums, chocolates, and sweets. It operates in Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific. Givaudan SA was founded in 1796 and is headquartered in Vernier, Switzerland.
Stock analysis
Givaudan SA (GIVN) currently trades at CHF 3,406, while our model-based Fair Value estimate is CHF 1,523, implying the stock looks roughly 123.7% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of CHF 1,727 per share, and 0 of the 25 models we run sit above the CHF 3,406 price.
Bear case: the Asset-Based group reads lowest at CHF 329.37, and 25 of the 25 models stay below the price. Evidence for this calculation is high.
Scenario range: CHF 1,024 (bear) to CHF 2,619 (bull), the price of CHF 3,406 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 70/100 (solid quality), in the Basic Materials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Givaudan SA reported revenue of CHF 7.5B in FY2025 versus CHF 6.7B in FY2021, a compound +2.8%/yr. Reported net income was CHF 1.1B in FY2025, compounding +6.9%/yr from FY2021.
Key figures
Market cap CHF 31.6B · P/E ratio 29.5 · P/S ratio 4.23 · EPS (TTM) CHF 115.54 · Dividend yield 2.1% · Net margin 14.3% · Return on equity 23.4% · Return on assets (EBIT) 10.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 4% below its 52-week high and 31% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at −55%, GIVN screens richer than that median.
Fair Value models
Bear CHF 1,024Fair Value CHF 1,523Bull CHF 2,619
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (CHF 31.84 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.75/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+0.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.4%
Start year 2020 (pandemic). Over 10 years: +5.4% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+9.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+7.6%
Dividend (yield on the price)2.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.8% vs 5%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 19%
Start year 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+12.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (Switzerland: IMF forecast 0.6% a year to 2030, 0.8% from 2016 to 2025) that is about +11.5% a year for the price and +3.6% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 712 stocks
Beats the industry median on 6/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score70 · Top 25%
Fair Value upside−55% · Below median
Profitability
Return on equity (TTM)23% · Top 25%
Return on assets7% · Top 25%
Net margin (TTM)14% · Top 25%
Operating margin (TTM)17% · Top 25%
Growth and dividend
Revenue growth−2% · Below median
Dividend yield (TTM)2.1% · Above median
Balance sheet
Debt / equity0.85× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (TTM)29.5× · Pricier than median
P/B8.39× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM)5.10× · Priciest 25%
P/FCF31.6× · Priciest 25%
EV/EBITDA25.4× · Priciest 25%
PEG4.87× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 21
PAST (return on equity)94· sector 23
HEALTH (low debt)58· sector 95
DIVIDEND (yield)42· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Givaudan SA Fair Value". https://www.fairvalue-calculator.com/stock/GIVN
Frequently asked questions
Is Givaudan SA (GIVN) overvalued or undervalued?
As of Sep 25, 2026, our model estimates a fair value of CHF 1,523 versus a price of CHF 3,406, about −55% upside (overvalued).
What is the fair value of GIVN?
Our model-based fair value for Givaudan SA is CHF 1,523 (as of Sep 25, 2026), built from audited fundamentals. The current price: CHF 3,406.
What is the quality score of GIVN?
Givaudan SA has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Givaudan SA (GIVN)?
Our model-based price target is the fair value of CHF 1,523 (as of Sep 25, 2026) from 25 valuation models. Cautious scenario CHF 1,024, optimistic scenario CHF 2,619. It is a calculation from audited fundamentals, not an analyst target.
What is the Givaudan SA stock forecast for 2026?
Our models put fair value at CHF 1,523, about −55% upside versus a price of CHF 3,406 (overvalued). Cautious scenario CHF 1,024, optimistic scenario CHF 2,619. The calculation is refreshed regularly with new filings.
What is the revenue of Givaudan SA (GIVN)?
Givaudan SA reported trailing-twelve-month revenue of about CHF 7.5B (latest available figure, as of Sep 25, 2026).
Does Givaudan SA pay a dividend?
Givaudan SA currently shows a dividend yield of about 2.11% relative to its recent price (as of Sep 25, 2026).
What growth is priced into Givaudan SA (GIVN)?
For today's price to be fair in a discounted-cash-flow model, Givaudan SA would have to grow free cash flow by +12.1 % per year for five years (discount rate 8.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.4 % per year. As of Sep 25, 2026.
What discount rate (WACC) does the fair value of GIVN use?
Our models discount Givaudan SA at 8.3 %: a base by market capitalisation (large), damped by beta 0.67, country premium for Switzerland. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Givaudan SA that is +12.1 % per year a year over ten years, using the same discount rate (8.3 %) and the same formula as our fair value.
How much growth has Givaudan SA (GIVN) delivered so far?
Over the past 5 years revenue at Givaudan SA grew +3.4 % a year. The price currently implies +12.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Givaudan SA (GIVN) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Givaudan SA (+12.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Givaudan SA (GIVN)?
The free-cash-flow yield on the price is 3.82 %: that much free cash flow Givaudan SA produces per unit of market value. When it exceeds the discount rate of our models (8.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Givaudan SA (GIVN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Givaudan SA it is CHF 1,523 per share (as of Sep 25, 2026), against a price of CHF 3,406. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is Givaudan SA stock overvalued or undervalued in 2026?
As of Sep 25, 2026, GIVN trades above its calculated fair value: price CHF 3,406, fair value CHF 1,523, a gap of about −55% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GIVN?
No. The price is what the market pays today (CHF 3,406); the fair value is what the company's own numbers justify (CHF 1,523). For Givaudan SA the two are CHF 1,883 per share apart. That gap is exactly why we show both numbers side by side.
How much is Givaudan SA worth?
The market values Givaudan SA at about CHF 31.6B (market capitalisation, as of Sep 25, 2026). Per share that is CHF 3,406; our models calculate a fair value of CHF 1,523 per share.
What do the bullish and bearish scenarios say about GIVN?
Our models span a range for Givaudan SA: cautious scenario CHF 1,024, base CHF 1,523, optimistic CHF 2,619 per share (as of Sep 25, 2026, price CHF 3,406). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of GIVN?
Givaudan SA trades at a price-to-earnings ratio of 29.5 (as of Sep 25, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of CHF 1,523 is built from several models across several years. Other multiples: PEG 4.9, P/B 8.4, P/S 5.1, EV/EBITDA 25.4.
What is the PEG ratio of GIVN?
The PEG ratio of Givaudan SA is 4.87 (P/E divided by earnings growth, as of Sep 25, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Givaudan SA (GIVN)?
Balance-sheet figures for Givaudan SA (as of Sep 25, 2026): return on equity 23.4%, debt of 0.85 per unit of equity. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is GIVN from its 52-week high?
Givaudan SA trades at CHF 3,406, about 4% below its 52-week high of CHF 3,536 and 31% above the low of CHF 2,606 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of CHF 1,523 is for.
Which stocks are comparable to Givaudan SA?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Givaudan SA stock attractive at the current price?
The data as of Sep 25, 2026: price CHF 3,406, calculated fair value CHF 1,523 (−55%), Quality Score 70/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GIVN calculated?
We run Givaudan SA through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of CHF 1,523, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Givaudan SA itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Givaudan SA (GIVN)?
The closing price on Sep 24, 2026 was CHF 3,406. Our model-based fair value is CHF 1,523, about −55% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Givaudan SA right now?
A high-quality business (quality 70/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (CHF 2,619). The favourable scenario is already priced in. A fairly wide model range (CHF 1,024 to CHF 2,619) leaves room in how you read the outcome.
Where does the earnings growth of Givaudan SA (GIVN) come from?
Earnings per share at Givaudan SA grew +5.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +5.6 %, EBIT margin +0.6 %, tax rate +0.0 %, residual (interest, one-offs) −0.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Givaudan SA
How large is the market capitalisation of Givaudan SA (GIVN)?
The market capitalisation of Givaudan SA is CHF 31.6B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Givaudan SA (GIVN)?
The price-to-sales ratio of Givaudan SA is 4.23 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Givaudan SA (GIVN)?
Earnings per share at Givaudan SA are CHF 115.54 (price ÷ EPS = P/E 29.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Givaudan SA (GIVN)?
The dividend yield of Givaudan SA is 2.1% (payout 62.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Givaudan SA (GIVN)?
The net margin of Givaudan SA is 14.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Givaudan SA (GIVN)?
The return on equity (ROE) of Givaudan SA is 23.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Givaudan SA (GIVN)?
On an EBIT basis the return on assets of Givaudan SA is 10.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Givaudan SA (GIVN)?
The operating margin of Givaudan SA is 16.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Givaudan SA (GIVN)?
Revenue at Givaudan SA is growing −1.8% versus a year earlier (3y avg +1.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Givaudan SA (GIVN)?
Earnings per share at Givaudan SA are growing −4.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Givaudan SA (GIVN) carry?
The net debt of Givaudan SA is CHF 3.7B (fiscal year 2025, ≈ 3.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Givaudan SA in the live analysis
One click puts Givaudan SA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Broad data
Sep 25, 2026